[Trial Data] nausea rates in the combination arm vs sema alone
Right, the amylin question again, but with numbers this time. I have 11 data points over 10 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…
long-acting amylin is co-agonism, different satiety profile
Removed a chain here. The rule is one line long and it is not negotiable.
REDEFINE phase 21 readouts are interesting but 21 person REDEFINE is different from 21 trial REDEFINE.
the mechanism is different, the side effect profile reflects it
This is correct. The co-agonism is real.
long-acting amylin is CagriSema, different satiety profile
long-acting amylin is CagriSema, different satiety profile
Adding to this: amylin is doing more work than the comment implies.